In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination
- 1 February 2004
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 61 (2), 111-117
- https://doi.org/10.1016/j.antiviral.2003.09.005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Structure of Isolated Nucleocapsids from Venezuelan Equine Encephalitis Virus and Implications for Assembly and Disassembly of Enveloped VirusJournal of Virology, 2003
- O'nyong‐nyong Fever in South‐Central Uganda, 1996–1997: Description of the Epidemic and Results of a Household‐Based Seroprevalence SurveyThe Journal of Infectious Diseases, 1999
- Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus InfectionsJournal of Interferon Research, 1990
- Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral DrugClinical Infectious Diseases, 1989
- Lassa FeverNew England Journal of Medicine, 1986
- Semliki Forest Virus: Cause of a Fatal Case of Human EncephalitisScience, 1979
- ANTIVIRAL ACTION AND SELECTIVITY OF 6‐AZAURIDINEAnnals of the New York Academy of Sciences, 1977
- Double-blind controlled crossover high-dose study of Azaribine in psoriasis*British Journal of Dermatology, 1975
- The Treatment of Psoriasis with AzarihineDermatology, 1975
- An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953Transactions of the Royal Society of Tropical Medicine and Hygiene, 1955